Lonza Lights Up Las Vegas with Science-Backed Ingredients and Formulations at SupplySide West 2019

September 27, 2019
  • Official Capsule Sponsor Lonza to showcase clean-label Vcaps® Plus capsule colors at SupplySide West 2019 (17-18 October, Las Vegas, USA)
  • Lonza to host “Consumer Driven Product Design” Central Stage event on Thursday, 17 October – 14:00-14:30 EDT.
  • Clinically studied ingredients for joint health, physical performance, infant nutrition and men’s health also on show at booth 4339.

Morristown, NJ (USA), 27 September 2019 Lonza  will be showcasing its comprehensive range of scientifically-backed ingredients and formulations for joint health, sports nutrition, men’s health, prenatal and digestive health at SupplySide 2019. At booth 4339, Lonza will highlight how today’s values-driven consumers seek products that help them live longer, healthier lives, that also align with their values and beliefs. Supplement manufacturers therefore need product strategies, and innovative formulations and technologies that are relevant, delight consumers, and respect the planet.

Beth Tormey, Senior Vice President, Lonza Consumer Health & Nutrition, comments: “Consumer expectations are evolving all the time. At Lonza Consumer Health & Nutrition, we are uniquely placed to support brand leaders and product designers to develop truly innovative products that will satisfy these demands and surprise and delight consumers.”

Visitors to SupplySide West can find out more about consumers’ health aspirations and purchasing behavior by attending Lonza’s Central Stage event “Consumer Driven Product Design” on Thursday, 17 October – 14:00-14:20 EDT.

Time for Natural Colors

As SupplySide West’s Official Capsule Sponsor, Lonza will also present its leading capsule and encapsulation technologies including its new clean-label colored capsules. Using capsules made from hypromellose (HPMC) and water only, and colors sourced from plant-based foods, Lonza’s Vcaps® Plus Purple Carrot capsules are the ideal solution for supplement brands looking to create unique visual appeal with a more natural capsule. In Canada, Lonza’s Vcaps® Plus Blue Spirulina colored capsules are also available.

Also being introduced at SupplySide West 2019 is Lonza’s Vcaps® Plus White Opal™ clean-label plant-based capsules. Offering a Titanium Dioxide-free formula, the capsules can be used outside of the US, by customers exporting to Europe and other regions.

Dosage Form Innovation

Offering advanced delivery solutions to challenging customer and consumer needs, Lonza’s innovative technologies address product bioavailability (Licaps® Liquid-filled capsules), achieve modified / targeted release (DUOCAP® capsules, DRcaps™ capsules and lipid multiparticulates) and improve consumer experience. Furthermore, its plant-based capsule portfolio presents high performance clean-label solutions for even the most discerning consumers and is on showcase via consumer-driven product concepts. Made from tapioca, which is naturally fermented into pullulan, Plantcaps® capsules are a more natural alternative and offer the best plant-based oxygen barrier on the market, protecting sensitive ingredients.

Science in Motion™

Lonza is also underwriting the SSW Sports Nutrition Summit on Wednesday, 16 October 09:00-17:00 EDT. Aligned with this event, its Science in Motion™ ingredients and concepts will be highlighted, including new Oceanix™ marine phytoplankton for peak physical performance and recovery. UC-II® undenatured type II collagen is another highlight following the recent launch of Lonza’s Lifestyle in Motion™ campaign, a major consumer education drive for joint health. Lonza will also host a sports-themed supplier session on Friday, 18 October 13:30-13:45 EDT at the Supplier Presentation Theater, booth #1266.

Visitors can book an appointment here to meet with the expert team from Lonza Consumer Health & Nutrition at booth 4339 at SupplySide West, or find out more information at www.lonza.com.  

About Lonza

Lonza is an integrated solutions provider that creates value along the Healthcare Continuum®. Through our Pharma Biotech & Nutrition segment and our Specialty Ingredients segment businesses, we harness science and technology to serve markets along this continuum. We focus on creating a healthy environment, promoting a healthier lifestyle and preventing illness through consumers' preventive healthcare, as well as improving patient healthcare by supporting our customers to deliver innovative medicines that help treat or even cure severe diseases.

Patients and consumers benefit from our ability to transfer our pharma know-how to the healthcare, hygiene and fast-moving consumer goods environment and to the preservation and protection of the world where we live.

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 15,500 full-time employees worldwide at the end of 2018. The company generated sales of CHF 5.5 billion in 2018 with a CORE EBITDA of CHF 1.5 billion. Further information can be found at www.lonza.com.

Lonza Contact Details      

Aparna Parikh
Head of Global Marketing Communications
Lonza Consumer Health & Nutrition
Tel +1.862.579.8400

Additional Information and Disclaimer

Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.

Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.